Compile Data Set for Download or QSAR
Report error Found 427 with Last Name = 'cantley' and Initial = 'lc'
TargetPhosphatidylinositol 5-phosphate 4-kinase type-2 gamma(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM690795(US20240277852, Compound 1)
Affinity DataKd:  36nMAssay Description:The inhibitory activity of the compounds were evaluated using KINOMEscan PIP5K2B (also known as PIP4K2B) and KINOMEscan PIP5K2C (also known as PIP4k2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
Go to US Patent

TargetPhosphatidylinositol 5-phosphate 4-kinase type-2 beta(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM690795(US20240277852, Compound 1)
Affinity DataKd: >1.00E+4nMAssay Description:The inhibitory activity of the compounds were evaluated using KINOMEscan PIP5K2B (also known as PIP4K2B) and KINOMEscan PIP5K2C (also known as PIP4k2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
Go to US Patent

TargetPhosphatidylinositol 5-phosphate 4-kinase type-2 gamma(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM691383(US20240277852, Compound 2)
Affinity DataKd:  56nMAssay Description:The inhibitory activity of the compounds were evaluated using KINOMEscan PIP5K2B (also known as PIP4K2B) and KINOMEscan PIP5K2C (also known as PIP4k2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
Go to US Patent

TargetPhosphatidylinositol 5-phosphate 4-kinase type-2 beta(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM691383(US20240277852, Compound 2)
Affinity DataKd: >1.00E+4nMAssay Description:The inhibitory activity of the compounds were evaluated using KINOMEscan PIP5K2B (also known as PIP4K2B) and KINOMEscan PIP5K2C (also known as PIP4k2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
Go to US Patent

TargetPhosphatidylinositol 5-phosphate 4-kinase type-2 gamma(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM691384(US20240277852, Compound 3)
Affinity DataKd:  29nMAssay Description:The inhibitory activity of the compounds were evaluated using KINOMEscan PIP5K2B (also known as PIP4K2B) and KINOMEscan PIP5K2C (also known as PIP4k2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
Go to US Patent

TargetPhosphatidylinositol 5-phosphate 4-kinase type-2 beta(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM691384(US20240277852, Compound 3)
Affinity DataKd: >1.00E+4nMAssay Description:The inhibitory activity of the compounds were evaluated using KINOMEscan PIP5K2B (also known as PIP4K2B) and KINOMEscan PIP5K2C (also known as PIP4k2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
Go to US Patent

TargetPhosphatidylinositol 5-phosphate 4-kinase type-2 gamma(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM691385(US20240277852, Compound 4)
Affinity DataKd:  64nMAssay Description:The inhibitory activity of the compounds were evaluated using KINOMEscan PIP5K2B (also known as PIP4K2B) and KINOMEscan PIP5K2C (also known as PIP4k2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
Go to US Patent

TargetPhosphatidylinositol 5-phosphate 4-kinase type-2 beta(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM691385(US20240277852, Compound 4)
Affinity DataKd: >1.00E+4nMAssay Description:The inhibitory activity of the compounds were evaluated using KINOMEscan PIP5K2B (also known as PIP4K2B) and KINOMEscan PIP5K2C (also known as PIP4k2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
Go to US Patent

TargetPhosphatidylinositol 5-phosphate 4-kinase type-2 gamma(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM691386(US20240277852, Compound 5)
Affinity DataKd:  46nMAssay Description:The inhibitory activity of the compounds were evaluated using KINOMEscan PIP5K2B (also known as PIP4K2B) and KINOMEscan PIP5K2C (also known as PIP4k2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
Go to US Patent

TargetPhosphatidylinositol 5-phosphate 4-kinase type-2 gamma(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM691387(US20240277852, Compound 6)
Affinity DataKd:  43nMAssay Description:The inhibitory activity of the compounds were evaluated using KINOMEscan PIP5K2B (also known as PIP4K2B) and KINOMEscan PIP5K2C (also known as PIP4k2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
Go to US Patent

TargetPhosphatidylinositol 5-phosphate 4-kinase type-2 gamma(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM691388(US20240277852, Compound 7)
Affinity DataKd:  150nMAssay Description:The inhibitory activity of the compounds were evaluated using KINOMEscan PIP5K2B (also known as PIP4K2B) and KINOMEscan PIP5K2C (also known as PIP4k2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
Go to US Patent

TargetPhosphatidylinositol 5-phosphate 4-kinase type-2 gamma(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM691389(US20240277852, Compound 8)
Affinity DataKd:  270nMAssay Description:The inhibitory activity of the compounds were evaluated using KINOMEscan PIP5K2B (also known as PIP4K2B) and KINOMEscan PIP5K2C (also known as PIP4k2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
Go to US Patent

TargetPhosphatidylinositol 5-phosphate 4-kinase type-2 gamma(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM691390(US20240277852, Compound 9)
Affinity DataKd:  1.40E+3nMAssay Description:The inhibitory activity of the compounds were evaluated using KINOMEscan PIP5K2B (also known as PIP4K2B) and KINOMEscan PIP5K2C (also known as PIP4k2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
Go to US Patent

TargetPhosphatidylinositol 5-phosphate 4-kinase type-2 beta(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM691390(US20240277852, Compound 9)
Affinity DataKd: >1.00E+4nMAssay Description:The inhibitory activity of the compounds were evaluated using KINOMEscan PIP5K2B (also known as PIP4K2B) and KINOMEscan PIP5K2C (also known as PIP4k2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
Go to US Patent

TargetPhosphatidylinositol 5-phosphate 4-kinase type-2 gamma(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM691391(US20240277852, Compound 10)
Affinity DataKd:  65nMAssay Description:The inhibitory activity of the compounds were evaluated using KINOMEscan PIP5K2B (also known as PIP4K2B) and KINOMEscan PIP5K2C (also known as PIP4k2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
Go to US Patent

TargetPhosphatidylinositol 5-phosphate 4-kinase type-2 gamma(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM691392(US20240277852, Compound 11)
Affinity DataKd:  7.20nMAssay Description:The inhibitory activity of the compounds were evaluated using KINOMEscan PIP5K2B (also known as PIP4K2B) and KINOMEscan PIP5K2C (also known as PIP4k2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
Go to US Patent

TargetPhosphatidylinositol 5-phosphate 4-kinase type-2 beta(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM691392(US20240277852, Compound 11)
Affinity DataKd: >1.00E+4nMAssay Description:The inhibitory activity of the compounds were evaluated using KINOMEscan PIP5K2B (also known as PIP4K2B) and KINOMEscan PIP5K2C (also known as PIP4k2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
Go to US Patent

TargetPhosphatidylinositol 5-phosphate 4-kinase type-2 gamma(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM691393(US20240277852, Compound 12)
Affinity DataKd:  140nMAssay Description:The inhibitory activity of the compounds were evaluated using KINOMEscan PIP5K2B (also known as PIP4K2B) and KINOMEscan PIP5K2C (also known as PIP4k2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
Go to US Patent

TargetPhosphatidylinositol 5-phosphate 4-kinase type-2 beta(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM691393(US20240277852, Compound 12)
Affinity DataKd: >1.00E+4nMAssay Description:The inhibitory activity of the compounds were evaluated using KINOMEscan PIP5K2B (also known as PIP4K2B) and KINOMEscan PIP5K2C (also known as PIP4k2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
Go to US Patent

TargetPhosphatidylinositol 5-phosphate 4-kinase type-2 gamma(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM691394(US20240277852, Compound 13)
Affinity DataKd:  21nMAssay Description:The inhibitory activity of the compounds were evaluated using KINOMEscan PIP5K2B (also known as PIP4K2B) and KINOMEscan PIP5K2C (also known as PIP4k2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
Go to US Patent

TargetPhosphatidylinositol 5-phosphate 4-kinase type-2 beta(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM691394(US20240277852, Compound 13)
Affinity DataKd: >1.00E+4nMAssay Description:The inhibitory activity of the compounds were evaluated using KINOMEscan PIP5K2B (also known as PIP4K2B) and KINOMEscan PIP5K2C (also known as PIP4k2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
Go to US Patent

TargetPhosphatidylinositol 5-phosphate 4-kinase type-2 gamma(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM691395(US20240277852, Compound 14)
Affinity DataKd:  38nMAssay Description:The inhibitory activity of the compounds were evaluated using KINOMEscan PIP5K2B (also known as PIP4K2B) and KINOMEscan PIP5K2C (also known as PIP4k2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
Go to US Patent

TargetPhosphatidylinositol 5-phosphate 4-kinase type-2 beta(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM691395(US20240277852, Compound 14)
Affinity DataKd: >1.00E+4nMAssay Description:The inhibitory activity of the compounds were evaluated using KINOMEscan PIP5K2B (also known as PIP4K2B) and KINOMEscan PIP5K2C (also known as PIP4k2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
Go to US Patent

TargetPhosphatidylinositol 5-phosphate 4-kinase type-2 gamma(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM691396(US20240277852, Compound 15)
Affinity DataKd:  0.450nMAssay Description:The inhibitory activity of the compounds were evaluated using KINOMEscan PIP5K2B (also known as PIP4K2B) and KINOMEscan PIP5K2C (also known as PIP4k2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
Go to US Patent

TargetPhosphatidylinositol 5-phosphate 4-kinase type-2 beta(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM691396(US20240277852, Compound 15)
Affinity DataKd: >1.00E+4nMAssay Description:The inhibitory activity of the compounds were evaluated using KINOMEscan PIP5K2B (also known as PIP4K2B) and KINOMEscan PIP5K2C (also known as PIP4k2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
Go to US Patent

TargetPhosphatidylinositol 5-phosphate 4-kinase type-2 gamma(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM691397(US20240277852, Compound 36)
Affinity DataKd:  460nMAssay Description:The inhibitory activity of the compounds were evaluated using KINOMEscan PIP5K2B (also known as PIP4K2B) and KINOMEscan PIP5K2C (also known as PIP4k2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
Go to US Patent

TargetPhosphatidylinositol 5-phosphate 4-kinase type-2 gamma(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM691398(US20240277852, Compound 53)
Affinity DataKd:  110nMAssay Description:The inhibitory activity of the compounds were evaluated using KINOMEscan PIP5K2B (also known as PIP4K2B) and KINOMEscan PIP5K2C (also known as PIP4k2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
Go to US Patent

TargetPhosphatidylinositol 5-phosphate 4-kinase type-2 gamma(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM691399(US20240277852, Compound 56)
Affinity DataKd:  620nMAssay Description:The inhibitory activity of the compounds were evaluated using KINOMEscan PIP5K2B (also known as PIP4K2B) and KINOMEscan PIP5K2C (also known as PIP4k2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
Go to US Patent

TargetPhosphatidylinositol 5-phosphate 4-kinase type-2 beta(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM691399(US20240277852, Compound 56)
Affinity DataKd: >1.00E+4nMAssay Description:The inhibitory activity of the compounds were evaluated using KINOMEscan PIP5K2B (also known as PIP4K2B) and KINOMEscan PIP5K2C (also known as PIP4k2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
Go to US Patent

TargetPhosphatidylinositol 5-phosphate 4-kinase type-2 gamma(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM691400(US20240277852, Compound 57)
Affinity DataKd:  42nMAssay Description:The inhibitory activity of the compounds were evaluated using KINOMEscan PIP5K2B (also known as PIP4K2B) and KINOMEscan PIP5K2C (also known as PIP4k2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
Go to US Patent

TargetPhosphatidylinositol 5-phosphate 4-kinase type-2 beta(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM691400(US20240277852, Compound 57)
Affinity DataKd: >1.00E+4nMAssay Description:The inhibitory activity of the compounds were evaluated using KINOMEscan PIP5K2B (also known as PIP4K2B) and KINOMEscan PIP5K2C (also known as PIP4k2...More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/26/2024
Entry Details
Go to US Patent

TargetPhosphatidylinositol 5-phosphate 4-kinase type-2 gamma(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM50527927(CHEMBL4436648)
Affinity DataKd:  1.60nMAssay Description:Binding affinity to human PI5P4IKgammaMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetPhosphatidylinositol 5-phosphate 4-kinase type-2 gamma(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM50527929(CHEMBL4455633)
Affinity DataKd:  3.40nMAssay Description:Binding affinity to human PI5P4IKgammaMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetPhosphatidylinositol 5-phosphate 4-kinase type-2 gamma(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM50527938(CHEMBL4454033)
Affinity DataKd:  0.0230nMAssay Description:Binding affinity to human PI5P4IKgammaMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetPhosphatidylinositol 5-phosphate 4-kinase type-2 gamma(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM50511422(CHEMBL4446338)
Affinity DataKd:  4.80nMAssay Description:Binding affinity to human PI5P4IKgammaMore data for this Ligand-Target Pair
In Depth
Date in BDB:
2/25/2021
Entry Details Article
PubMed
TargetPhosphatidylinositol 5-phosphate 4-kinase type-2 gamma(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM50625379(CHEMBL5408017)
Affinity DataKd:  270nMAssay Description:Binding affinity to full length wild type human PI5P4Kgamma assessed as dissociation constant by KINOMEscan KdELECT assayMore data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/18/2024
Entry Details
PubMed
TargetPhosphatidylinositol 5-phosphate 4-kinase type-2 gamma(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM50625380(CHEMBL5413905)
Affinity DataKd:  340nMAssay Description:Binding affinity to full length wild type human PI5P4Kgamma assessed as dissociation constant by KINOMEscan KdELECT assayMore data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/18/2024
Entry Details
PubMed
TargetPhosphatidylinositol 5-phosphate 4-kinase type-2 gamma(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM50625381(CHEMBL5427799)
Affinity DataKd:  420nMAssay Description:Binding affinity to full length wild type human PI5P4Kgamma assessed as dissociation constant by KINOMEscan KdELECT assayMore data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/18/2024
Entry Details
PubMed
TargetPhosphatidylinositol 5-phosphate 4-kinase type-2 gamma(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM50625382(CHEMBL5397185)
Affinity DataKd:  330nMAssay Description:Binding affinity to full length wild type human PI5P4Kgamma assessed as dissociation constant by KINOMEscan KdELECT assayMore data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/18/2024
Entry Details
PubMed
TargetPhosphatidylinositol 5-phosphate 4-kinase type-2 gamma(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM50625383(CHEMBL5440896)
Affinity DataKd:  670nMAssay Description:Binding affinity to full length wild type human PI5P4Kgamma assessed as dissociation constant by KINOMEscan KdELECT assayMore data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/18/2024
Entry Details
PubMed
TargetPhosphatidylinositol 5-phosphate 4-kinase type-2 gamma(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM50625384(CHEMBL5436468)
Affinity DataKd:  230nMAssay Description:Binding affinity to full length wild type human PI5P4Kgamma assessed as dissociation constant by KINOMEscan KdELECT assayMore data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/18/2024
Entry Details
PubMed
TargetPhosphatidylinositol 5-phosphate 4-kinase type-2 gamma(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM50625385(CHEMBL5436645)
Affinity DataKd:  270nMAssay Description:Binding affinity to full length wild type human PI5P4Kgamma assessed as dissociation constant by KINOMEscan KdELECT assayMore data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/18/2024
Entry Details
PubMed
TargetPhosphatidylinositol 5-phosphate 4-kinase type-2 gamma(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM50625386(CHEMBL5418854)
Affinity DataKd:  230nMAssay Description:Binding affinity to full length wild type human PI5P4Kgamma assessed as dissociation constant by KINOMEscan KdELECT assayMore data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/18/2024
Entry Details
PubMed
TargetPhosphatidylinositol 5-phosphate 4-kinase type-2 gamma(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM50625387(CHEMBL5436714)
Affinity DataKd:  870nMAssay Description:Binding affinity to full length wild type human PI5P4Kgamma assessed as dissociation constant by KINOMEscan KdELECT assayMore data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/18/2024
Entry Details
PubMed
TargetPhosphatidylinositol 5-phosphate 4-kinase type-2 gamma(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM50625388(CHEMBL5432791)
Affinity DataKd:  570nMAssay Description:Binding affinity to full length wild type human PI5P4Kgamma assessed as dissociation constant by KINOMEscan KdELECT assayMore data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/18/2024
Entry Details
PubMed
TargetPhosphatidylinositol 5-phosphate 4-kinase type-2 gamma(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM50625389(CHEMBL5400791)
Affinity DataKd:  490nMAssay Description:Binding affinity to full length wild type human PI5P4Kgamma assessed as dissociation constant by KINOMEscan KdELECT assayMore data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/18/2024
Entry Details
PubMed
TargetPhosphatidylinositol 5-phosphate 4-kinase type-2 gamma(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM50625390(CHEMBL5428687)
Affinity DataKd:  150nMAssay Description:Binding affinity to full length wild type human PI5P4Kgamma assessed as dissociation constant by KINOMEscan KdELECT assayMore data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/18/2024
Entry Details
PubMed
TargetPhosphatidylinositol 5-phosphate 4-kinase type-2 gamma(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM50625391(CHEMBL5396741)
Affinity DataKd:  330nMAssay Description:Binding affinity to full length wild type human PI5P4Kgamma assessed as dissociation constant by KINOMEscan KdELECT assayMore data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/18/2024
Entry Details
PubMed
TargetPhosphatidylinositol 5-phosphate 4-kinase type-2 gamma(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM50625392(CHEMBL5418550)
Affinity DataKd:  270nMAssay Description:Binding affinity to full length wild type human PI5P4Kgamma assessed as dissociation constant by KINOMEscan KdELECT assayMore data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/18/2024
Entry Details
PubMed
TargetPhosphatidylinositol 5-phosphate 4-kinase type-2 gamma(Human)
Dana-Farber Cancer Institute

US Patent
LigandPNGBDBM50625393(CHEMBL5419800)
Affinity DataKd:  220nMAssay Description:Binding affinity to full length wild type human PI5P4Kgamma assessed as dissociation constant by KINOMEscan KdELECT assayMore data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
12/18/2024
Entry Details
PubMed
Displayed 1 to 50 (of 427 total ) | Next | Last >>
Jump to: